KUEHNE&NAGEL INTL UNSP ADR EACH REPR 0.20 (NASDAQ:KHNGY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Tuesday.

According to Zacks, “Kuehne + Nagel International AG is a logistics company. It operates through six segments: Seafreight, Airfreight, Road & Rail Logistics, Contract Logistics, Real Estate, and Insurance Brokers. The Company is engaged in transportation services, including carrier services and contracts of carriage related to shipment; provision of services related to warehouse and distribution activities; brokerage services of insurance coverage, mainly marine liability; and covers activities mainly related to internal rent of facilities. It operates in Europe, the Americas, the Asia-Pacific, the Middle East, Central Asia, and Africa. Kuehne + Nagel International AG is headquartered in Schindellegi, Switzerland. “

Shares of KUEHNE&NAGEL INTL UNSP ADR EACH REPR 0.20 (NASDAQ:KHNGY) remained flat at $28.78 on Tuesday. 2 shares of the company’s stock were exchanged. The firm has a market cap of $17.36 billion and a PE ratio of 23.98. The firm’s 50-day moving average is $28.38 and its 200 day moving average is $28.04. KUEHNE&NAGEL INTL UNSP ADR EACH REPR 0.20 has a 52-week low of $24.70 and a 52-week high of $29.25.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/zacks-investment-research-upgrades-kuehnenagel-intl-unsp-adr-each-repr-0-20-khngy-to-hold.html


5 Day Chart for NASDAQ:KHNGY

Receive News & Ratings for KUEHNE&NAGEL INTL UNSP ADR EACH REPR 0.20 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KUEHNE&NAGEL INTL UNSP ADR EACH REPR 0.20 and related companies with MarketBeat.com's FREE daily email newsletter.